Chuanju Liu

This inventor holds 6 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: New York University. Active years: 2011-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chuanju Liu. Retrieved from https://idiyas.com/inventor/chuanju-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 2)

% Patents Active = 66.7

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 1.6

ph-index = 2

Forward Citations = 12(Granted Patents)

Company Filing History:

6 out of 1,727

New York University

patents

Years Active: 2011-2022

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11390656 - Progranulin (PGRN) fragments and derivatives for treatment or alleviation of lysosomal storage diseases (2022-07-19),

2. 10357542 - Progranulin (PGRN) and its derivatives for diagnosis and treatment of lysosomal storage diseases (2019-07-23),

3. 8871915 - Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof (2014-10-28),

4. 8536128 - Granulin/epithelin precursor (GEP), a chondrogenic growth factor and target in cartilage disorders (2013-09-17),

5. 8362218 - Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof (2013-01-29),

6. 7928068 - Methods for using GEP, a chondrogenic growth factor and target in cartilage disorders (2011-04-19),

Title: Innovations of Chuanju Liu in Lysosomal Storage Diseases

Introduction

Chuanju Liu is a prominent inventor based in Orange, Connecticut, known for his significant contributions to the field of medical research, particularly in the treatment of lysosomal storage diseases. With a total of 6 patents to his name, Liu has made remarkable strides in developing innovative therapies that address complex health issues.

Latest Patents

Liu's latest patents focus on the use of progranulin (PGRN) fragments and derivatives for the treatment and alleviation of lysosomal storage diseases. One of his notable inventions provides peptides, compositions, and methods for treating conditions such as Gaucher's Disease. This invention utilizes one or more PGRN derivatives or fragments, particularly the ND7/Pcgin fragment. Another significant patent involves the use of PGRN and its derivatives for the diagnosis and treatment of lysosomal storage diseases, including Tay-Sachs disease. This invention also includes the development of animal models based on PGRN mutations, which are essential for understanding these diseases better.

Career Highlights

Chuanju Liu is affiliated with New York University, where he continues to advance his research and innovations. His work has garnered attention for its potential to transform the treatment landscape for lysosomal storage diseases, which are often challenging to manage.

Collaborations

Liu collaborates with esteemed colleagues such as Sally Frenkel and Jinlong Jian, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Chuanju Liu's contributions to the field of lysosomal storage diseases through his innovative patents and collaborative efforts highlight his commitment to advancing medical science. His work not only addresses critical health challenges but also paves the way for future research and development in this vital area.

Profile summary based on public USPTO records.